The New York Stock Exchange welcomes Johnson & Johnson (NYSE: JNJ) to the podium. NYSE Big pharmaceutical companies such as Bristol Myers
Tag: Karuna Therapeutics Inc
Bristol-Myers CEO talks new acquisitions: ‘Writing the next chapter’
Bristol-Myers Squibb CEO Chris Boerner detailed the pharmaceutical giant’s bundle of recent acquisitions in a Monday interview with CNBC’s Jim Cramer, and
Cramer names biopharma companies as industry mergers start to accrue
CNBC’s Jim Cramer on Friday pointed out the number of biopharma mergers and acquisitions that have closed or been announced over the
Investors see a biotech comeback in 2024 as rates fall, deal-making picks up. Stocks to watch
Many biotech stocks struggled in 2023 despite a robust year for U.S. drug approvals. As these new therapies begin treating patients, some
Stocks making the biggest moves midday: NKE, RKLB, BMY, NTES
Check out the companies making headlines in midday trading. Nike , Foot Locker — Shares of Nike plummeted 11.8% after the athletic
Bristol Myers Squibb to buy Karuna Therapeutics
Bristol Myers Squibb on Friday announced it agreed to buy biopharmaceutical company Karuna Therapeutics for $14 billion in cash, or $330 per
10 things to watch in the stock market Friday, including Nike, inflation
10 things to watch Friday, Dec. 22 Wall Street indicated for a mixed open Friday as the November personal consumption expenditures (PCE)
No More Posts Available.
No more pages to load.